DOI:
10.1055/s-00000034
Klinische Pädiatrie
LinksClose Window
References
Kelly WK, Richon VM, O’Connor O. et al.
Phase I clinical trial of histone deacetylase inhibitor: suberoylanilide hydroxamic acid administered intravenously.
Clin Cancer Res 2003; 9: 3578-3588
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.